Facebook Linkedin Twitter
Inside Precision Medicine CellMaxLife Results Say Blood Test Can Detect CRC at Near-90% Accuracy

CellMax Life

polyp removal
News & Features

CellMaxLife Results Say Blood Test Can Detect CRC at Near-90% Accuracy

0
CellMax Life's CMxTM circulating tumor cell (CTC) platform and liquid biopsy panel will be used by Medigen Biotech in upcoming clinical trials of its cell therapy candidates for cancers
Molecular Dx

Medigen to Use CellMax Life CTC Blood Test in Trials of Cancer Cell Therapies

0
CellMax Life aims to win FDA approval for its circulating tumor cell (CTC) blood test designed to detect colorectal cancer. The test has been marketed for two yers in Asia
Molecular Dx

CellMax Life Launches Clinical Study for Colorectal Cancer CTC Blood Test

0
Clinical OMICs Magazine Volume 5, Issue No. 3
News & Features

Clinical OMICs Magazine Volume 5, Issue No. 3

0
Woman donating blood
Molecular Dx

CellMax Life, IncellDx to Jointly Market and Develop CTC-based Liquid Biopsy Diagnostics

0
Projections for the growth of the liquid biopsy market range as low as $1 billion by 2020
Molecular Dx

10 Liquid Biopsy Companies in the Money

Alex Philippidis
0

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine